About Contact Us Careers
Sign In

Soft Tissue Allografts Market Size & Share, by Type (Cartilage, Tendon, Meniscus, Dental, Collagen, Amniotic Allograft); Application (Orthopedic, Dentistry, Wound Care); End-user (Hospitals, Orthopedic Clinics, Aesthetic Centers, Dental Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4344
  • Published Date: Feb 24, 2023
  • Report Format: PDF, PPT

Companies Dominating the Soft Tissue Allografts Landscape

top-features-companies
    • Stryker Corporation
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • ALON SOURCE GROUP
    • CONMED Corporation
    • LifeSciences Corporation
    • Organogenesis Inc.
    • RTI Surgical, Inc.
    • MIMEDX, Inc.
    • Xtant Medical Holdings, Inc.
    • Globus Medical, Inc.
    • Bone Bank Allografts
Browse Key Market Insights with Data Illustration:

In the News

  •  AlloSource, one of the leading providers of allograft in the United States, announced the launch of AlloMend Extra Large (XL) Acellular Dermal Matrix (ADM). It is so far the biggest dermal graft launched by the company. It is available in mesh and non-mesh variations for use in demanding soft tissue applications.

  • RTI Surgical, Inc. and Zimmer Biomet partnered with the American Academy of Implant Dentistry Foundation (AAIDF) to provide dental implants and wound care products for an initiative supporting veterans of the United States Armed Forces.

 


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4344
  • Published Date: Feb 24, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing incidences of sports injuries, rising prevalence of osteoarthritis, increase in trauma cases, and upsurge in musculoskeletal diseases are the major factors driving the market growth.

The market is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2023-2035.

High cost of treatment, unfavorable compensation policies, and lack of skilled personnel are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Stryker Corporation, ALON SOURCE GROUP, CONMED Corporation, Integra LifeSciences Corporation, Organogenesis Inc., RTI Surgical, Inc., MIMEDX, Inc., and Xtant Medical Holdings, Inc.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, application, end user, and by region.

The dentistry segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying